Company / CIK 0000943819
RESMED INC
- Ticker
- RMD
- Size, estimated from filings
- Large cap ($10B – $200B)
- Insiders on file
- 5
- Members of Congress who traded it
- 2
- Federal contracts on record
- none matched
- Lobbying filings on record
- 12
- SEC filings
- EDGAR ↗
- Latest trade on record
- October 7, 2026
RESMED INC (RMD) has 5 insiders on file who disclosed 21 transactions in the last 12 months (0 open-market buys, 7 sales, about $11.0M at reported prices), and 2 congressional trades in its stock are on record. No federal contract award that started in the last 180 days was found for a recipient with exactly this name, and 7 lobbying filings naming it as client report $420K in 2026.
RESMED INC in charts
Who is trading this stock
Which people account for the buying and selling over the last 12 months?
3 people account for the disclosed buying and selling in RESMED INC over the last 12 months; the most active is Farrell Michael J. with $5.3M.
Lobbying spend by quarter
How much has RESMED INC reported spending on federal lobbying?
RESMED INC reported $610K in lobbying over the last eight quarters, from filings matched by exact company name.
Insiders
| Name | Role | Rows | Bought | Sold | Last filed |
|---|---|---|---|---|---|
| Farrell Michael J. | Director | 16 | 0 | 5 | October 8, 2026 |
| Leong Justin | Chief Product Officer | 1 | 0 | 0 | October 1, 2026 |
| Rider Michael J | Global General Counsel | 1 | 0 | 0 | October 1, 2026 |
| Bloomer Aaron | Chief Financial Officer | 1 | 0 | 0 | October 1, 2026 |
| FARRELL PETER C | Director | 2 | 0 | 2 | September 4, 2026 |
Rows are this company's Form 4 rows for each person. "Bought" and "sold" count open-market purchases (code P) and sales only. More in insider buying and insider selling.
Members of Congress who traded RMD
From periodic transaction reports that name the company's stock. Amounts are the sums of the ranges as filed. Every row is on the RMD page.
| Member | Seat | Trades | Bought | Sold | Range as filed | Latest |
|---|---|---|---|---|---|---|
| Alan Armstrong | Senator (OK), Republican | 1 | 1 | 0 | $1,001–$15K | March 27, 2026 |
| Tommy Tuberville | Senator (AL), Republican | 1 | 0 | 1 | $1,001–$15K | May 3, 2024 |
Insider transactions
| Filer | Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Farrell Michael J. | RMD | Option / conversion M | October 7, 2026 | October 8, 2026 | 1d | 4,991 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| Farrell Michael J. | RMD | Sell S | October 7, 2026 | October 8, 2026 | 1d | 4,991 | $226 | $1.1M | 10b5-1 plan | Form 4 ↗ | |
| Farrell Michael J. | RMD | Option / conversion M | October 7, 2026 | October 8, 2026 | 1d | 4,991 | $146 | $730K | 10b5-1 plan | Form 4 ↗ | |
| Bloomer Aaron | RMD | Other A | August 14, 2026 | October 1, 2026 | 48d | 9,072 | — | — | late | Form 4 ↗ | |
| Farrell Michael J. | RMD | Other A | August 14, 2026 | October 1, 2026 | 48d | 13,547 | — | — | late | Form 4 ↗ | |
| Rider Michael J | RMD | Other A | August 14, 2026 | October 1, 2026 | 48d | 3,230 | — | — | late | Form 4 ↗ | |
| Leong Justin | RMD | Other A | August 14, 2026 | October 1, 2026 | 48d | 6,461 | — | — | late | Form 4 ↗ | |
| Farrell Michael J. | RMD | Option / conversion M | September 8, 2026 | September 10, 2026 | 2d | 4,991 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| Farrell Michael J. | RMD | Sell S | September 8, 2026 | September 10, 2026 | 2d | 4,991 | $222 | $1.1M | 10b5-1 plan | Form 4 ↗ | |
| Farrell Michael J. | RMD | Option / conversion M | September 8, 2026 | September 10, 2026 | 2d | 4,991 | $146 | $730K | 10b5-1 plan | Form 4 ↗ | |
| FARRELL PETER C | RMD | Sell S | September 2, 2026 | September 4, 2026 | 2d | 970 | $235 | $228K | 10b5-1 plan | Form 4 ↗ | |
| Farrell Michael J. | RMD | Option / conversion M | August 7, 2026 | August 11, 2026 | 4d | 4,991 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| Farrell Michael J. | RMD | Sell S | August 7, 2026 | August 11, 2026 | 4d | 4,991 | $206 | $1.0M | 10b5-1 plan | Form 4 ↗ | |
| Farrell Michael J. | RMD | Option / conversion M | August 7, 2026 | August 11, 2026 | 4d | 4,991 | $146 | $730K | 10b5-1 plan | Form 4 ↗ | |
| FARRELL PETER C | RMD | Sell S | August 5, 2026 | August 6, 2026 | 1d | 8,000 | $225 | $1.8M | 10b5-1 plan | Form 4 ↗ | |
| Farrell Michael J. | RMD | Option / conversion M | July 7, 2026 | July 9, 2026 | 2d | 4,991 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| Farrell Michael J. | RMD | Sell S | July 7, 2026 | July 9, 2026 | 2d | 4,991 | $219 | $1.1M | 10b5-1 plan | Form 4 ↗ | |
| Farrell Michael J. | RMD | Option / conversion M | July 7, 2026 | July 9, 2026 | 2d | 4,991 | $146 | $730K | 10b5-1 plan | Form 4 ↗ | |
| Farrell Michael J. | RMD | Option / conversion M | June 8, 2026 | June 9, 2026 | 1d | 4,991 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| Farrell Michael J. | RMD | Sell S | June 8, 2026 | June 9, 2026 | 1d | 4,991 | $194 | $968K | 10b5-1 plan | Form 4 ↗ | |
| Farrell Michael J. | RMD | Option / conversion M | June 8, 2026 | June 9, 2026 | 1d | 4,991 | $146 | $730K | 10b5-1 plan | Form 4 ↗ |
Federal contracts (USAspending, awards started in the last 180 days)
No contract award starting in the last 180 days was found for a recipient named exactly "RESMED INC". Subsidiaries and differently-spelled recipients are not matched — search contracts.
Lobbying (Senate LDA, as client)
| Period | Registrant | Primary issue | Amount | Source |
|---|---|---|---|---|
| 2026 Q3 | AKIN GUMP STRAUSS HAUER & FELD | Tariff (miscellaneous tariff bills) | $110,000 | LDA ↗ |
| 2026 Q3 | TAFT STETTINIUS & HOLLISTER LLP DBA TAFT ADVISORS LLC FKA (TAFT, STETTINIUS & HO | Manufacturing | $20,000 | LDA ↗ |
| 2026 Q3 | TAFT STETTINIUS & HOLLISTER LLP DBA TAFT ADVISORS LLC FKA (TAFT, STETTINIUS & HOLLISTER,LLP) | Health Issues | — | LDA ↗ |
| 2026 Q2 | AKIN GUMP STRAUSS HAUER & FELD | Tariff (miscellaneous tariff bills) | $110,000 | LDA ↗ |
| 2026 Q2 | ICE MILLER LLP | Manufacturing | $30,000 | LDA ↗ |
| 2026 Q1 | AKIN GUMP STRAUSS HAUER & FELD | Tariff (miscellaneous tariff bills) | $110,000 | LDA ↗ |
| 2026 Q1 | ICE MILLER LLP | Manufacturing | $40,000 | LDA ↗ |
| 2025 Q4 | AKIN GUMP STRAUSS HAUER & FELD | Medicare/Medicaid | $90,000 | LDA ↗ |
| 2025 Q4 | ICE MILLER LLP | Manufacturing | $40,000 | LDA ↗ |
| 2025 Q3 | DLA PIPER LLP (US) | Health Issues | $40,000 | LDA ↗ |
| 2025 Q3 | AKIN GUMP STRAUSS HAUER & FELD | Medicare/Medicaid | $20,000 | LDA ↗ |
| 2025 Q3 | ICE MILLER LLP | Manufacturing | — | LDA ↗ |
Related companies
Companies whose stock was traded by the same people who traded RMD, by number of filers in common. It shows overlap in public filings and nothing else.
- HERSHEY CO HSY 2 filers in common
- NETFLIX INC NFLX 2 filers in common
- ADOBE INC. ADBE 2 filers in common
- ELI LILLY & Co LLY 2 filers in common
- Accenture plc ACN 2 filers in common
- CHEVRON CORP CVX 2 filers in common
- QUALCOMM INC/DE QCOM 2 filers in common
- PROCTER & GAMBLE Co PG 2 filers in common
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- Lobbying disclosure reports Reports are due about 20 days after each quarter ends.
- What disclosure data cannot tell you Filings are late by design: up to 45 days for Congress, two business days for insiders.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| Senate eFD, periodic transaction reports | 2 | 2 | July 21, 2026 | August 5, 2026 | Senate eFD search |
| SEC EDGAR, Form 4 | 11 | 21 | June 9, 2026 | October 8, 2026 | Form 4 list on EDGAR |
| Lobbying disclosure filings | 12 filings | — | — | — | LDA.gov search |
Site built October 22, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Insiders and their transactions come from SEC EDGAR Form 4 filings for this issuer. Contracts and lobbying are matched by exact normalized name (suffixes like Inc./Corp. ignored) to USAspending recipients and LDA clients — a conservative match that misses subsidiaries on purpose. See methodology and corrections.
Not investment advice. Public records shown as filed; no recommendation is made or implied.